David L. Dunner

Q: What Schools Are Affiliated With David L. Dunner

David L. Dunner is affiliated with the following schools: University of Washington, Columbia University

David L. Dunner's AcademicInfluence.com Rankings

David L. Dunner

Biology

#7018

World Rank

#9863

Historical Rank

biology Degrees

Download Badge

Biology

David L. Dunner's Degrees

Doctorate Medicine University of Washington
PhD Psychiatry University of Washington

Why Is David L. Dunner Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David L. Dunner's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. (2006) (1487)
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. (2000) (1290)
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma (2003) (740)
Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. (2008) (533)
Clinical factors in lithium carbonate prophylaxis failure. (1974) (498)
Brain metabolic alterations in medication-free patients with bipolar disorder. (2004) (402)
Effectiveness of St John's wort in major depression: a randomized controlled trial. (2001) (370)
Heritable factors in the severity of affective illness. (1976) (348)
A One-Year Comparison of Vagus Nerve Stimulation with Treatment as Usual for Treatment-Resistant Depression (2005) (323)
A Controlled Study of Repetitive Transcranial Magnetic Stimulation in Medication-Resistant Major Depression (2006) (311)
Regional cerebral cortical thinning in bipolar disorder. (2006) (289)
Frontal lobe gray matter density decreases in bipolar I disorder (2004) (259)
TRANSCRANIAL MAGNETIC STIMULATION (TMS) FOR MAJOR DEPRESSION: A MULTISITE, NATURALISTIC, OBSERVATIONAL STUDY OF ACUTE TREATMENT OUTCOMES IN CLINICAL PRACTICE (2012) (258)
Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique. (1973) (236)
Diagnostic reliability of the history of hypomania in bipolar II patients and patients with major depression. (1993) (220)
Lithium-Induced Gray Matter Volume Increase As a Neural Correlate of Treatment Response in Bipolar Disorder: A Longitudinal Brain Imaging Study (2010) (215)
Does psychosocial functioning improve independent of depressive symptoms? a comparison of nefazodone, psychotherapy, and their combination (2002) (214)
Lithium response in unipolar versus bipolar depression. (1972) (209)
Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression. (2006) (192)
The effect of alcohol and substance abuse on the course of bipolar affective disorder. (1996) (182)
Clinical consequences of under-recognized bipolar spectrum disorder. (2003) (177)
A prospective safety surveillance study for bupropion sustained-release in the treatment of depression. (1998) (171)
Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder (2004) (151)
The course of development of mania in patients with recurrent depression. (1976) (148)
Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. (1994) (144)
Rapid cycling manic depressive patients. (1977) (143)
Dawn simulation and bright light in the treatment of SAD: a controlled study (2001) (136)
Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. (1976) (135)
Vagus Nerve Stimulation Therapy Randomized to Different Amounts of Electrical Charge for Treatment-Resistant Depression: Acute and Chronic Effects (2013) (133)
Self-Reported Depressive Symptom Measures: Sensitivity to Detecting Change in a Randomized, Controlled Trial of Chronically Depressed, Nonpsychotic Outpatients (2005) (132)
Relatives at Risk for Mental Disorder (1988) (132)
Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness. (1976) (128)
The Tridimensional Personality Questionnaire in depression: state versus trait issues. (1996) (126)
Personality features of patients with primary affective disorder (1979) (122)
Relationship of childhood physical and sexual abuse to adult bipolar disorder. (2000) (122)
Reduced Catechol-O-Methyltransferase Activity in Red Blood Cells of Women with Primary Affective Disorder (1970) (122)
Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression. (2004) (120)
Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study. (1986) (117)
The analgesic effects of caffeine in headache (1991) (116)
A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. (2014) (115)
Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo (1995) (114)
Efficacy of controlled-release paroxetine in the treatment of late-life depression. (2003) (113)
Comorbidity of Mood and Anxiety Disorders. (1991) (108)
Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder. (1978) (107)
Toward a biology of affective disorders. Genetic contributions. (1971) (104)
Handbook of Affective Disorders, 2nd ed (1993) (103)
Basal ganglia shape alterations in bipolar disorder. (2006) (103)
Secondary depression in anxiety disorders. (1981) (102)
Life events at the onset of bipolar affective illness. (1979) (101)
Effect of L-tryptophan on brain serotonin metabolism in depressed patients. (1972) (101)
Acute and maintenance treatment of chronic depression. (2001) (99)
Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. (1992) (96)
Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial. (2001) (94)
Repetitive transcranial magnetic stimulation in the treatment of medication-resistant depression: preliminary data. (1999) (92)
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. (2007) (92)
The life table. A method for analyzing longitudinal studies. (1976) (91)
The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression. (2003) (88)
Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. (1994) (88)
DSM-III-R personality disorders in a mood and anxiety disorders clinic: prevalence, comorbidity, and clinical correlates. (1993) (87)
Bipolar illness: a prospective study of life events. (1977) (86)
Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study. (2007) (83)
Duloxetine in treatment of anxiety symptoms associated with depression (2003) (83)
Toward the validation of RDC schizoaffective disorder. (1980) (82)
Differential catechol-O-methyltransferase activity in unipolar and bipolar affective illness. (1971) (82)
Panic disorder precipitated by exposure to organic solvents in the work place. (1987) (80)
The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder. (1985) (80)
Lithium Carbonate Prophylaxis Failure (1976) (79)
The effect of lithium treatment on thyroid function in patients with primary affective disorder. (1979) (79)
Diagnostic assessment. (1993) (77)
A review of antidepressant-induced hypomania in major depression: suggestions for DSM-V. (2004) (76)
Randomized, Placebo-Controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression (2003) (75)
The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders (2008) (74)
Chronicity of depressive episode in relation to antidepressant-placebo response. (1991) (74)
Rapid cycling bipolar disorder--diagnostic concepts. (2008) (73)
Dawn simulation treatment of winter depression: a controlled study. (1993) (73)
Relationship between borderline personality disorder and Axis I diagnosis in severity of depression and anxiety. (1999) (72)
Age at onset and number of psychotic symptoms in bipolar I and schizoaffective disorder. (1983) (71)
Menstrual problems in women with primary affective illness. (1976) (71)
Bipolar illness: factors in drinking behavior. (1979) (70)
Transcranial Magnetic Stimulation Reduces Pain in Patients With Major Depression: A Sham-Controlled Study (2007) (69)
Morning or evening bright light treatment of winter depression? The significance of hypersomnia (1991) (69)
Cognitive therapy versus fluoxetine in the treatment of dysthymic disorder. (1996) (68)
Clinical and differential diagnostic aspects of treatment-resistant depression. (1995) (67)
Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling. (2003) (66)
Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression. (2009) (65)
Cardiac sinus node dysfunction during lithium treatment. (1979) (64)
A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression. (1998) (64)
Lithium treatment in older patients. (1979) (63)
Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination. (2002) (63)
Rubidium: biochemical, behavioral, and metabolic studies in humans. (1973) (60)
Coping in panic and major depressive disorder. Relative effects of symptom severity and diagnostic comorbidity. (1992) (60)
Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study (2016) (56)
Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression. (2002) (56)
Depressive symptoms in patients with unipolar and bipolar affective disorder. (1976) (53)
Statistical predictions of suicide in depressives. (1980) (52)
Psychotic symptoms in patients with bipolar mania. (2008) (51)
Unipolar mania: a distinct clinical entity? (1979) (51)
Assortative mating in the affective disorders. (1973) (51)
The effect of L-DOPA treatment on brain serotonin metabolism in depressed patients. (1971) (51)
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. (2007) (50)
The symptom‐specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta‐analysis (2019) (50)
Onset of response in relation to outcome in depressed outpatients with placebo and imipramine. (1989) (50)
Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. (2003) (49)
Plasma DOPA response to levodopa administration in man: Effects of a peripheral decarboxylase inhibitor (1971) (49)
Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study. (2007) (49)
Social Outcome Compared in Psychotic and Nonpsychotic Bipolar I Patients (1983) (49)
Excretion of 17-OHCS in unipolar and bipolar depressed patients. (1972) (49)
Lithium carbonate and weight gain. (1980) (49)
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the Acute and Continuation Phases (2007) (48)
Lithium prophylaxis of depression in unipolar, bipolar II, and cyclothymic patients. (1982) (48)
Lithium carbonate in affective disorders. IV. A double-blind study of prophylaxis in unipolar recurrent depression. (1975) (47)
Incidence of side effects in patients on long-term lithium therapy. (1980) (47)
Safety and tolerability of emerging pharmacological treatments for bipolar disorder. (2005) (47)
Preventing recurrent depression: long-term treatment for major depressive disorder. (2007) (46)
A review of the diagnostic status of “Bipolar II” for the DSM‐IV work group on mood disorders (1993) (44)
Biological markers in panic states: Lactate-induced panic and mitral valve prolapse (1987) (44)
Long-Term Safety and Clinical Acceptability of: Venlafaxine and Imipramine in Outpatients (1994) (44)
A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder. (2006) (43)
Assortative mating in primary affective disorder. (1976) (43)
Validity of seasonal pattern as a modifier for recurrent mood disorders for DSM-IV. (1993) (43)
Adinazolam--a new antidepressant: findings of a placebo-controlled, double-blind study in outpatients with major depression. (1987) (41)
A comparison of initial duloxetine dosing strategies in patients with major depressive disorder. (2007) (41)
Optimizing lithium treatment. (2000) (41)
The activity of dopamine-beta-hydroxylase and methionine-activating enzyme in blood of schizophrenic patients. (1973) (41)
The relationship between anxiety and depression: a clinical comparison of generalized anxiety disorder, dysthymic disorder, panic disorder, and major depressive disorder. (1992) (40)
Search for biological/genetic markers in a long-term epidemiological and morbid risk study of affective disorders. (1984) (40)
Personality traits and early discontinuation from clinical trials in anxious patients. (1993) (40)
Psychopathology among children of manic-depressive patients. (1980) (38)
Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release. (2010) (38)
Psychosis as a predictor of response to lithium maintenance treatment in bipolar affective disorder. (1979) (38)
The occurrence of cavum septi pellucidi enlargement is increased in bipolar disorder patients. (2007) (38)
Management of anxiety disorders: The added challenge of comorbidity (2001) (38)
Relapse and rebound following discontinuation of benzodiazepine treatment of panic attacks: alprazolam versus diazepam. (1989) (38)
Tachyphylaxis after Repeated Antidepressant Drug Exposure in Patients with Recurrent Major Depressive Disorder (2009) (37)
Lactate infusions: The role of baseline anxiety (1987) (37)
Medicare patient experience with vagus nerve stimulation for treatment-resistant depression (2013) (35)
Therapeutic considerations in treating depression in the elderly. (1994) (35)
A Double-Blind Study of Paroxetine, Fluoxetine, and Placebo an Outpatients with Major Depression (1998) (34)
Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients (1994) (33)
Life events and primary affective illness (1978) (33)
Differential subtyping of depression (2001) (33)
Clinical characteristics and response to sodium lactate of patients with infrequent panic attacks. (1987) (33)
Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice (2013) (32)
Treatment resistance in unipolar depression and other disorders. Diagnostic concerns and treatment possibilities. (1993) (32)
Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression. (2005) (32)
American Psychiatric Press Textbook of Psychopharmacology, 2nd ed. (1998) (32)
Clinical consequences of initial duloxetine dosing strategies: Comparison of 30 and 60 mg QD starting doses. (2005) (32)
Comparative efficacy of propranolol, chlordiazepoxide, and placebo in the treatment of anxiety: a double-blind trial. (1987) (31)
Current Psychiatric Therapy II (1997) (31)
Drug interactions of lithium and other antimanic/mood-stabilizing medications. (2003) (31)
Platelet MAO-B activity in anxiety and depression (1986) (31)
Lactate-induced panic in primary affective disorder. (1986) (30)
Classification of bipolar affective disorder subtypes. (1982) (30)
Genetic polymorphisms in the treatment of depression: Speculations from an augmentation study using atomoxetine (2010) (29)
Differentiation of anxious patients by two-dimensional echocardiographic evaluation of the mitral valve. (1986) (29)
Erythrocyte catechol-o-methyltransferase activity in primary affective disorder. (1977) (29)
Correlates of suicidal behavior and lithium treatment in bipolar disorder. (2004) (28)
Ziprasidone monotherapy in bipolar II depression: an open trial. (2009) (28)
Erratum: Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma (Proceedings of the National Academy of Sciences of the United States of America (November 25, 2003) 100, 24 (14293-14296)) (2005) (28)
Psychopathology in systemic lupus erythematosus. II. Relation to clinical observations, corticosteroid administration, and cerebrospinal fluid C4. (1973) (27)
L-tryptophan in depression. (1976) (27)
Treatement of excessive weight gain in patients taking lithium. (1976) (27)
The relationship of family history of alcoholism to primary affective disorder. (1979) (27)
Reinventing Depression: A History of the Treatment of Depression in Primary Care, 1940-2004 (2006) (26)
Episode frequency prior to lithium treatment in bipolar manic-depressive patients. (1979) (26)
No Change in Neuropsychological Functioning After Receiving Repetitive Transcranial Magnetic Stimulation Treatment for Major Depression (2014) (26)
Amino acid concentrations in cerebrospinal fluid: effects of aging, depression, and probenecid. (1980) (26)
Early placebo response in anxious and depressed patients. (1986) (26)
Suicide attempts in rapid cycling bipolar disorder patients. (1993) (25)
Prostaglandins. A review of neurophysiology and psychiatric implications. (1977) (25)
Rapid Cycling Bipolar Manic Depressive Illness (1979) (25)
Lactate vulnerability after alprazolam versus placebo treatment of panic disorder (1991) (24)
Atypical antipsychotics: efficacy across bipolar disorder subpopulations. (2005) (24)
Self and other directed violence on a closed acute-care ward (2005) (23)
Lithium elimination half‐life and duration of therapy (1981) (23)
Venlafaxine in dysthymic disorder. (1997) (22)
Prophylaxis with lithium carbonate: an update. (1982) (22)
Response to lactate infusion in generalized anxiety disorder (1988) (22)
Efficacy and tolerability of controlled-release paroxetine in the treatment of severe depression: post hoc analysis of pooled data from a subset of subjects in four double-blind clinical trials. (2005) (22)
A randomized, double-blind study of increasing or maintaining duloxetine dose in patients without remission of major depressive disorder after initial duloxetine therapy. (2008) (21)
The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic. (1995) (21)
Assessing rates and predictors of tachyphylaxis during the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) study. (2009) (21)
Suicide attempt history in depressed patients with and without a history of panic attacks. (1995) (21)
Improved Health-Related Quality of Life and Reduced Productivity Loss After Treatment With Bupropion Sustained Release: A Study in Patients With Major Depression. (2001) (20)
Unipolar and Bipolar Depression: Recent Findings from Clinical and Biologic Studies (1980) (19)
Age of onset of affective illness. (1982) (19)
Sexual Functioning in Patients With Recurrent Major Depressive Disorder Enrolled in the PREVENT Study (2013) (19)
Cogwheel rigidity during chronic lithium therapy. (1979) (19)
Clinical correlates of the lithium pump. (1978) (18)
Differential Diagnosis of Bipolar Disorder (1992) (18)
bright light treatment of winter depression: Am compared to PM light (1989) (18)
Long‐term tolerability and effectiveness of duloxetine in the treatment of major depressive disorder (2008) (17)
Lactate infusions in major depression without panic attacks. (1987) (17)
Platelet monoamine oxidase activity in affective disorder. (1980) (17)
Marital adjustment in primary affective disorder. (1978) (17)
The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication. (2004) (17)
Psychiatric illness in fathers of men with bipolar primary affective disorder. (1975) (17)
Revising Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC project (2018) (17)
Psychiatry and Clinical Neuroscience: A Primer (2012) (17)
Repression of a lithium pump as a consequence of lithium ingestion by manic-depressive subjects (1977) (16)
Pharmacotherapy for Mood, Anxiety, and Cognitive Disorders (2000) (16)
Paroxetine: a review of clinical experience. (1998) (16)
Actuarial studies of the course of manic-depressive illness. (1978) (16)
Bipolar Disorders in DSM-IV: Impact of Inclusion of Rapid Cycling as a Course Modifier (1998) (16)
Treatment Considerations for Depression in the Elderly (2003) (15)
Social adjustment in primary affective disorder. (1978) (15)
Bipolar disorder not otherwise specified in relation to the bipolar spectrum (2007) (14)
Characteristics of placebo response during long-term treatment of panic disorder. (1990) (14)
Lithium pharmacokinetics, duration of therapy, and the adenylate cyclase system. (1982) (14)
Lithium carbonate prophylaxis of depression in three subtypes in primary affective disorder. (1976) (14)
Treatment Options in Severe Psychotic Depression. (1987) (14)
PLASMA AND ERYTHROCYTE MAGNESIUM LEVELS IN PATIENTS WITH PRIMARY AFFECTIVE DISORDER DURING CHRONIC LITHIUM TREATMENT (1975) (14)
An overview of paroxetine in the elderly. (1994) (14)
Dysthymia and double depression (2005) (13)
Catecholamines and Affective Illness: Studies with L-DOPA and Alpha-Methyl-Para-Tyrosine (1971) (13)
Refined diagnostic criteria for the bipolar disorders: phase two of the AREDOC project (2020) (13)
Repression and reactivation of lithium efflux from erythrocytes (1979) (13)
Is morning light exposure superior to evening light in treating seasonal affective disorder? (1990) (13)
Lithium erythrocyte: plasma ratio in primary affective disorder. (1978) (12)
L-Tryptophan in the maintenance treatment of bipolar II manic-depressive illness. (1982) (12)
Mitral valve abnormalities and catecholamine activity in anxious patients (1987) (12)
Anxiety and panic: relationship to depression and cardiac disorders. (1985) (12)
Bipolar II disorder (2017) (12)
Depression and axis II disorders: Comorbidity and relationship to cooperativeness. (1996) (12)
Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depression. (1989) (12)
Plasma beta-endorphin response to lactate infusion (1989) (11)
The effect of lithium on red blood cell cholinesterase activity in patients with affective disorders. (1976) (11)
Assortative Mating in Affective and Anxiety Disorders: Preliminary Findings (1990) (11)
Introduction: New Strategies for Improving the Treatment of Depression (2000) (11)
Treatment of dysthymic disorder (1998) (11)
Endocrine and Metabolic Effects of Lithium (1987) (10)
The American Psychiatric Press Textbook of Psychopharmacology (1995) (10)
The relationship of the lithium erythrocyte: plasma ratio to plasma lithium level. (1979) (10)
Long-term outcome of panic states during double-blind treatment and after withdrawal of alprazolam and placebo (1992) (10)
Descriptive validity and stability of diagnostic criteria for dysthymic disorder. (1995) (10)
The prophylactic efficacy of tricyclic antidepressants—A five year followup (1991) (10)
Duration of periods of euthymia in patients with dysthymic disorder. (1999) (9)
Antidepressant-Induced Hypomania in Treatment-Resistant Depression (2007) (9)
Dysthymic disorder: Treatment with mirtazapine (1999) (9)
A report on three patients with "rapid cycling" unipolar depression. (1992) (9)
International Review of Psychiatry, vol. 1 (1995) (9)
Response to sodium lactate in panic disorder: Relationship to presenting clinical variables (1988) (9)
97 CLINICAL CHARACTERISTICS OF BIPOLAR DISORDER NOT OTHERWISE SPECIFIED IN RELATION TO THE BIPOLAR SPECTRUM (2005) (9)
A Report of Trazodone‐Associated Laboratory Abnormalities (1990) (8)
The assessment of cognitive dysfunction in dementing illness. (1980) (8)
Mitral valve prolapse in a psychiatric setting diagnostic assessment research and clinical implications (1986) (8)
Plasma and cerebrospinal fluid probenecid concentrations as related to accumulation of acidic biogenic amine metabolites in man (1974) (8)
A case of nonneuroleptic malignant syndrome. (1987) (8)
Prostaglandin F in patients with primary affective disorder. (1977) (8)
rTMS effects in patients with co-morbid somatic pain and depressive mood disorders. (2018) (8)
The bipolar disorders: A case for their categorically distinct status based on symptom profiles. (2020) (8)
Lithium carbonate: maintenance studies and consequences of withdrawal. (1998) (8)
Combining antidepressants (2014) (8)
Body composition in affective disorder before, during, and after lithium carbonate therapy. (1982) (8)
Sub-types of bipolar affective disorder with particular regard to bipolar II. (1983) (8)
Social Origins of Distress and Disease: Depression, Neurasthenia, and Pain in Modern China (1987) (8)
Chart review of alcohol problems in adolescent psychiatric patients in an emergency room. (1983) (7)
Lithium-associated nephropathy. (1979) (7)
Oxiracetam in the treatment of primary dementia of the Alzheimer's type: A small case series (1992) (7)
Bioavailability of lithium carbonate: single versus multiple daily dosing. (1981) (7)
Differentiating mania/hypomania from happiness using a machine learning analytic approach. (2020) (7)
The Psychobiology of the Depressive Disorders: Implications for the Effects of Stress (1980) (7)
404. The effect of substance abuse on the course of bipolar disorder (1996) (7)
"A two-illness model of bipolar disorder"--RT Joffe, LT Young, and GM MacQueen: a commentary. (1999) (6)
Affective episode frquency and lithium therapy. (1980) (6)
DST results in nonpsychotic depressed outpatients. (1988) (6)
Hospitalization effect in acute mania. (1988) (6)
Treatment-Resistant Bipolar Disorder: A Comparison of Rapid Cyclers and Nonrapid Cyclers (2003) (6)
First Onset of Schizophrenia (2006) (5)
Differences in lithium kinetics between bipolar and unipolar patients. (1982) (5)
Joseph Wortis, M.D. a new position: Founding editor (1993) (5)
Safety and efficacy of esketamine nasal spray in a depressed patient who was being treated with tranylcypromine: A case report (2020) (5)
Repetitive Transcranial Magnetic Stimulation in the Treatment of Bipolar Depression: Experience From a Clinical Setting (2020) (5)
The issue of comorbidity in the treatment of panic. (1998) (5)
Psychiatric disorders and the need for mental health services among a sample of orthopedic inpatients. (1976) (5)
Relationship between plasma lithium levels and prophylaxis against depression in bipolar I, bipolar II, and cyclothymic patients. (1982) (5)
HIGH RISK STUDIES IN AFFECTIVE DISORDERS (1982) (5)
Comparative safety and tolerability of nefazodone (2002) (5)
Stahl’s Essential Psychopharmacology Online, revised and updated 3rd ed (2009) (5)
Genetic Studies in Affective Disorders: Overview of Basic Methods, Current Directions, and Critical Research Issues (1995) (5)
Major Depressive Disorder (2008) (4)
Rubidium replacement of total body potassium in humans. (1980) (4)
Acute viral encephalitis complicating a first manic episode. (1984) (4)
Prophylactic effect of lithium against depression in cyclothymic patients: a life-table analysis. (1981) (4)
Handbook of Depression and Anxiety: A Biological Approach (1996) (4)
Long-term use of sedative and hypnotic medication. (1999) (4)
Affective disorder: studies with amine precursors. (1975) (4)
Dysthymic disorder: Treatment with citalopram (2001) (4)
Stability of bipolar II affective disorder as a diagnostic entity. (1987) (4)
Chapter 24 Lithium use in clinical practice (2000) (3)
Maintenance treatment of unipolar depression. (1981) (3)
High-risk studies: the impact of research design on research results. (1987) (3)
Mitral valve prolapse and the anxiety disorders. (1988) (3)
Etiology of Mental Disorder (1992) (3)
CSF AMP in primary affective disorder: effects of probenecid and tryptophan. (1980) (3)
Treatment-resistant depression: An overview of the problem (2005) (3)
Plasma dopamine Β hydroxylase activity in affective disorders (1976) (3)
Bipolar II Disorder: Recognition, Understanding, and Treatment. (2020) (3)
Bipolar Disorder: A Guide for Patients and Families, 2nd ed; Depression: The Mood Disease, 3rd ed (2007) (3)
The Phenomenology of Bipolar I Manic-Depressive Illness (1982) (3)
Treatment of Bipolar Disorder in the Elderly. (2017) (3)
Depression: What We Know: DHHS Publication ADM-84-1318 (1986) (3)
Cerebrospinal fluid rubidium metabolism in depression (1974) (3)
THE EFFECT OF LITHIUM IN DEPRESSIVE SUBTYPES (1978) (3)
Commentary on “Placebo as a Treatment for Depression” (1994) (2)
SUN DC: AN IMPROVED TECHNIC FOR TUBELESS GASTRIC ANALYSIS. (1964) (2)
Bipolar II--a distinct diagnostic entity? (1981) (2)
Bipolar II Disorder: Modelling, Measuring and Managing, 2nd ed (2014) (2)
Psychotropic Drug Handbook, 7th ed. (1998) (2)
Lithium and amino acids. (1982) (2)
Factors affecting lithium efflux from human erythrocytes [proceedings]. (1978) (2)
Plasma dopamine beta hydroxylase activity in affective disorders. (1976) (2)
Depressive Illness: Biological and Psychopharmacological Issues (1984) (2)
Diagnostic reliability of M-mode echocardiography for detecting mitral valve prolapse in 50 consecutive panic patients. (1989) (2)
Lithium and Manic Depression: A Guide (1982) (2)
Bipolar Disorder: A Guide for Patients and Families, 2nd ed. (2007) (2)
Lithium pump repression as an indicator of prophylactic response [proceedings]. (1978) (2)
Beneficial effects of adjunctive aripiprazole in major depressive disorder are not dependent on antidepressant therapy history: a post hoc analysis of 3 randomized, double-blind, placebo-controlled trials. (2012) (2)
Treatment-resistant Depression (2013) (2)
The issue of comorbidity in the of panic (1998) (2)
Two-year placebo-controlled maintenance study to assess recurrence prevention with venlafaxine XR in patients with recurrent unipolar major depression (2007) (2)
Handbook of Psychiatric Drug Therapy: A Lippincott Williams & Wilkins Handbook, 6th ed. (2010) (2)
Acid-Fastness of pine pollen (1963) (1)
P.2.c.019 Two-year maintenance treatment study assessing recurrence prevention with venlafaxine XR in patients with recurrent unipolar major depression (2006) (1)
P.2.a.016 Prevalence and clinical correlates of pain in patients with recurrent major depressive disorder (2007) (1)
Shared brain changes in bipolar and panic disorder (2008) (1)
Lactate response in patients with primary major depression (1989) (1)
The Antidepressant Sourcebook: A User’s Guide for Patients and Families (2001) (1)
Subject Index Vol. 59, 2009 (2009) (1)
Pharmacotherapy of Depression (2004) (1)
DIAGNOSTIC RELIABILITY OF HYPOMANIA (1992) (1)
A new machine learning-derived screening measure for differentiating bipolar from unipolar mood disorders (2021) (1)
Venlafaxine in the treatment of unresolved symptoms of depression following antidepressant therapy (2007) (1)
Toward a Pathophysiology of Bipolar Disorder (2000) (1)
Relationship of anxiety disorders to affective disorders (1983) (1)
New Directions in Affective Disorders (1990) (1)
Being an Editor of a Psychiatric Journal (2014) (1)
The importance of dietary control in metabolic studies of manic-depressive patients. (1980) (1)
Paliperidone extended-release (ER) in patients with schizoaffective disorder presenting with manic or depressive symptomatology (2010) (1)
Depression: challenges for the future. (1991) (1)
Anxiety and Depression in the Elderly: Implications for Diagnosis and Treatment (2003) (1)
Abstract of communications to the psychiatric research society, Boston, Massachusetts, September 26–27, 1980Hemodialysis for schizophrenia (1981) (1)
Structural brain changes in bipolar disorder (2008) (1)
Differentiation of various forms of depression (2012) (1)
Categorical differentiation of the unipolar and bipolar disorders (2021) (1)
Current therapeutic approaches for dysthymic disorder (2003) (1)
Clinical Manual of Drug Interaction: Principles for Medical Practice (2010) (1)
Depression, Dementia, or Pseudodementia? (2005) (1)
Improving the quality of care for depressed patients with comorbid psychiatric disorders: a review. (1997) (0)
Multiple Perspectives on Bipolar Disorder (2003) (0)
Comorbidity in Affective Disorders (2000) (0)
Dawn simulation treatment of winter depression: A controlled study David Avery, Mary Ann Bolte, Matthew Weyer, Stephen Dager, Lawrence Wilson, David Dunner, Gary Cox Harborview Medical Center, Seattle, WA 98104 (1992) (0)
Major Depression: Prevention and Treatment (1986) (0)
5 Depressive Disorder (2008) (0)
Brain chemical alterations in bipolar disorder:evidence of mitochondrial abnormalities? (2008) (0)
Depression: The Mood Disease, 3rd ed. (2007) (0)
Recurrence prevention in patients with recurrent major depression receiving 12 months of treatment with venlafaxine XR (2007) (0)
[The repression of the lithium pump as an indicator of the response to prophylactic treatment]. (1980) (0)
Clinical and demographic features related to placebo and antidepressant response (1989) (0)
Depression in Britain. (1991) (0)
and Safety in Chronic Major Depression. (2002) (0)
Depression in the Elderly (2005) (0)
A Comparison of Clinical and Judicial Procedures for Reviewing Requests for Involuntary Medication in New York (1988) (0)
The effect of l-tryptophan administration on the concentration of probenecid in plasma and cerebrospinal fluid in patients (1977) (0)
S-23-3 Rapid cycling bipolar disorder: An update (1996) (0)
ASCP Model Psychopharmacology Curriculum, 2nd ed., volumes 1 and 2 (2003) (0)
A study of primary affective disorder in the People's Republic of China. (1984) (0)
Mirtazapine and nortriptyline similarly effective third-line treatments for depression (2007) (0)
Toward a Pathophysiology of Bipolar Disorders (2007) (0)
Depression: The Mood Disease, 3rd ed (2007) (0)
Six-year perspectives on the safety and tolerability of nefazodone. (2002) (0)
Dorland's psychiatry & psychology speller (1993) (0)
rTMS effects in patients with co-morbid somatic pain and depressive mood disorders (2018) (0)
Recent Genetic Studies of Bipolar and Unipolar Depression (2018) (0)
Research report Psychotic symptoms in patients with bipolar mania (2008) (0)
P-18-10 Effect of substance abuse on the course of Bipolar Disorder (1996) (0)
Robert L. Spitzer, MD 1932-2015. (2016) (0)
Elcectroconvulsive Therapy, 4th ed. (2004) (0)
Annual Conference of the Swiss Society of Sleep Research, Sleep Medicine and Chronobiology (SSSSC) and the Swiss Society of Biological Psychiatry (SSBP). Sleepless Mind. Mindless Sleep? Bern, March 25 and 26, 2009 (2009) (0)
Course and relationship of lithium side effects to plasma lithium levels. (1981) (0)
Depressive Disorders: Facts, Theories, and Treatment Methods (1992) (0)
Bipolar Depression (2005) (0)
Advances in the Management and Treatment of Depression (2004) (0)
PMH38: RESPONSE TO NEFAZODONE, CBASP, AND COMBINED THERAPY: IMPLICATIONS FOR CHRONIC DEPRESSION SEVERITY, FUNCTIONAL STATUS AND ECONOMIC OUTCOMES (2000) (0)
Double Depression (2005) (0)
Reply to Misdiagnosis of Bipolar II Disorder as Major Depressive Order (2008) (0)
Randomized pilot study of two maintenance strategies of NeuroStar Transcranial Magnetic Stimulation in patients with major depression (2015) (0)
Treatment resistant depression: Clinical characteristics (1994) (0)
Erratum to: The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the Acute and Continuation Phases (2012) (0)
Erratum to “Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study” [Brain Stimulation 9 (2016) 251–257] (2016) (0)
Original article Medicare patient experience with vagus nerve stimulation for treatment-resistant depression (2013) (0)
Brain gray matter increase in drug-naïve bipolar disorder patients with lithium treatment but not with valproate treatment: A long-term longitudinal follow-up brain imaging study (2008) (0)
Dual Arm Randomized Pilot Study of Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients with Major Depression - Interim Analysis (2014) (0)
CATECHOLAMINE METABOLIZING ENZYMES AND PRIMARY AFFECTIVE DISORDERS (1979) (0)
C.14.01 Discerning differences in antidepressants: Clinical trial design, mets-analysis and outcomes interpretation (2004) (0)
Depression and Mania (1989) (0)
CNS volume 18 issue 6 Cover and Front matter (2013) (0)
2013 Reviewers (2013) (0)
Roles and Qualifications of TMS Treatment Team Members. (2018) (0)
90-106 Treatment of dysthymic disorder with venlafaxine (1997) (0)
Essential Evidence-Based Psychopharmacology, 2nd ed (2013) (0)
Psychiatry in China: some personal observations. (1983) (0)
Ronald R Fieve (2018) (0)
Pain, stress, and anxiety interrelationships and treatment necessities (2005) (0)
Acknowledgement to Reviewers 2019 (2020) (0)
Effective Treatments Despite Diagnostic Complexity and Diverse Populations (2009) (0)
First Episode: Depression and Panic Disorder (2005) (0)
A Randomized Pilot Study of Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients with Major Depression (2015) (0)
Paroxetine Controlled Release (2004) (0)
P.2.a.015 Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study (2006) (0)
Bipolar, Not So Much: Understanding Your Mood Swings and Depression (2018) (0)
Bipolar II Disorder: Recognition, Understanding, and Treatment. (2020) (0)
IN MEMORIAM Joseph Zubin, ph. D. 1900-1990 Compr (1991) (0)
Neurobiology of Mental Illness (2000) (0)
Mental disorders in children and adolescents: A message from the president (1992) (0)
Das Jahrestreffen der American Psychopathological Association in New York (2006) (0)
Clinical Handbook of Psychotropic Drugs (2002) (0)
Pharmacological treatment of mood disorders (1995) (0)
Title Page / Table of Contents, Supplement 1, 1994 (1994) (0)
The Prophylaxis of Unipolar Depression (1993) (0)
Management of treatment resistant bipolar depression with rTMS (2018) (0)
Drug therapy: predictors of response (2003) (0)
New insights into bipolar disorder using novel imaging technologies (2008) (0)
The use of erythrocyte catechol-O-methyltransferase activity as a possible marker for vulnerability of affective disorder. (1979) (0)
Book Review Try to Remember: Psychiatry's Clash over Meaning, Memory, and Mind By Paul R. McHugh. 276 pp. Washington, DC, Dana Press, 2008. $25. 978-1-932594-39-3 (2009) (0)
Contents of the American Journal of Psychiatry (2005) (0)
Contents Vol. 59, 2009 (2009) (0)
Proceedings: Amine precursors in depression: studies combining L-DOPA and L-tryptophan. (1974) (0)
Our final editorial. (2018) (0)
Joseph Zubin, Ph.D. 1900–1990 (1991) (0)
Personal recollections about the development of Bipolar II disorder (2023) (0)
Active Treatment of Depression (2002) (0)
Schizoaffective Disorder: Criteria and Prevalence-Reply (1981) (0)
Selective serotonin reuptake inhibitors: Therapeutic alternatives to the tricyclics in the treatment of major depression (1995) (0)
Dr. Dager and Associates Reply (1988) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David L. Dunner?

David L. Dunner is affiliated with the following schools: